2025 first_quarter Filing
Q1Income
$40K
Filed
April 21, 2025
Lobbying Activities
Health IssuesView all
Issues related to the research and development of cannabis-derived therapies and FDA's regulatory framework for CBD. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug value, including H.R. 1492, to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program; H.R. 946, Orphan Cures Act; and implementation of the Inflation Reduction Act (PL 117-169). Issues related to the regulation of hemp-derived cannabinoids. H.R.946 - ORPHAN Cures Act.
Contacted:Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Budget/AppropriationsView all
Issues related to budget reconciliation, including H.Con.Res. 14 and S.Con.Res. 7.
HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (2)
HAZEN CLAY MARSHALL
Policy Director-Senate Majority Leader Mitch McConnell; Staff Director/Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles
MONICA POPP
Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint